In one paragraphReview in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
25 authors.
Aleksandra CzerwDepartment of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0002-6189-6678 Andrzej DeptałaDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0003-2640-2043 Olga PartykaDepartment of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0001-6359-2902 Monika PajewskaDepartment of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0002-7735-5219 Anna Badowska-KozakiewiczDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0002-4990-8760 Michał BudzikDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0001-6222-9079 Zygmunt KopczyńskiFaculty of Medicine and Health Sciences, Calisia University, 62-800 Kalisz, Poland.
Magdalena KoniecznyMedical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.
Tomasz BanaśDepartment of Radiotherapy, Maria Sklodowska-Curie Institute-Oncology Center, 31-115 Cracow, Poland.ORCID 0000-0002-6656-2490 Elżbieta GrochansDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0002-3679-7002 Szymon GrochansDepartment of Pediatric and Oncological Surgery, Urology and Hand Surgery, Faculty of Medicine and Dentistry, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Anna Maria CybulskaDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0002-6912-287X Daria Schneider-MatykaDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
Ewa BandurskaCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.
Weronika CiećkoCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.ORCID 0000-0002-1496-1924 Jarosław DrobnikDepartment of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.ORCID 0000-0001-5472-1485 Piotr PobrotynPulsantis Specialist and Rehabilitation Clinic Ltd., 53-238 Wroclaw, Poland.
Urszula Grata-BorkowskaDepartment of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.ORCID 0000-0003-3783-0481 Joanna Furtak-PobrotynCitodent Dental Center Furtak-Pobrotyn & Company Limited Partnership, 05-220 Olawa, Poland.
Aleksandra SierockaDepartment of Management and Logistics in Healthcare, Medical University of Lodz, 90-131 Lodz, Poland.
Remigiusz KozlowskiDepartment of Management and Logistics in Healthcare, Medical University of Lodz, 90-131 Lodz, Poland.ORCID 0000-0003-2781-5341 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
backgroundThe World Health Organisation reports that melanoma had an incidence of 331,722 cases worldwide in 2022, ranking it 17th on the list of the most prevalent malignancies. This disease is a threat to public health as years of potential life lost from melanoma deaths constitute an economic and social burden; it is, however, curable if detected early. This study aims to show current trends in clinical trials for melanoma screening. MATERIALS AND
methodsThe analysis was conducted using data from clinicaltrials.gov. The analysis considered both interventional and observational studies on melanoma screening. Only the studies with complete and active statutes by 4 September 2024 were included in the analysis.
resultsOut of 25 studies registered in clinical trial databases regarding melanoma screening, 20% research advanced imagining techniques employing innovative machine learning algorithms, while 16% explore behavioural interventions.
conclusionsIntensification of behavioural interventions and health promotion activities is recommended.
Indexed as
clinical trialsmelanomaMMscreening
Identifiers
PMID39766085
PMCPMC11674172
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390